EV Biologics, Inc. (YECO) |
0.6221 0.02 (3.32%) 04-26 15:04 |
Open: | 0.6021 |
High: | 0.6221 |
Low: | 0.6021 |
Volume: | 3,220 |
Market Cap: | 4(M) |
PE Ratio: | -0.5 |
Exchange: | Other OTC |
Industry: | Biotechnology |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 37.54 |
Resistance 1: | 32.14 |
Pivot price: | 30.67 |
Support 1: | 30.60 |
Support 2: | 29.65 |
52w High: | 1.95 |
52w Low: | 0.563 |
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 35.16 |
Operating Margin (%) | 36.99 |
Return on Assets (ttm) | 10.9 |
Return on Equity (ttm) | 35.0 |
Mon, 07 Aug 2023
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director - Yahoo Canada Finance
Thu, 18 Oct 2018
US-Traded, Low Float Chinese Stocks Are Going Crazy - EV Biologics (OTC:YECO) - Benzinga
Fri, 26 Apr 2024
Fri, 26 Apr 2024
Fri, 26 Apr 2024
Fri, 26 Apr 2024
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |